Clinical Trials · NCT02172313

Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

CompletedPhase 1Semaglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
78
Start date
Jun 2014
Locations
1 site, Germany
Primary endpoint
Area under the semaglutide plasma concentration time curve
View Semaglutide compound reference